Wayland Group Corp. (MRRCF)

Market Cap	237.00
Revenue (ttm)	2.07M
Net Income (ttm)	-33.23M
Shares Out	237.26M
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	350
Average Volume	23,108
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	n/a
Beta	-58.26
RSI	48.37
Earnings Date	n/a

About Wayland Group

Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 68
• Stock Exchange: OTCMKTS
• Ticker Symbol: MRRCF

Financial Performance

In 2017, Wayland Group's revenue was 3.22 million, a decrease of -20.62% compared to the previous year's 4.06 million. Losses were -67.01 million, 707.8% more than in 2016.

Financial numbers in CAD